Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition - Takeaway - MDSpire
Feature

Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition

Ms. Carrillo was diagnosed with neuromyelitis optica (NMO), a rare autoimmune disease that affects the central nervous system, primarily targeting the optic nerves and spinal cord.

  • April 10, 2026

  • 6 min

Share

  • 1

    Dulima Carrillo experienced rapid neurological decline due to NMO.

  • 2

    Prompt diagnosis and treatment were crucial for recovery.

  • 3

    Treatment involved inebilizumab therapy.

  • 4

    Multidisciplinary care from neurologists and neuro-ophthalmologists improved outcomes.

  • 5

    NMO symptoms can escalate quickly, leading to severe disability.

  • 6

    Dulima regained her independence through intensive rehabilitation.

  • 7

    Importance of mindfulness and focusing on health post-recovery.

  • 8

    NMO is a rare but serious autoimmune condition.

Original Source(s)

Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition

  • April 10, 2026

Related Content

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

Midlife Vitamin D Linked to Lower Tau

Higher vitamin D levels in early midlife were tied to lower tau burden on later brain imaging, while no association was seen with amyloid.

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes